Home Products RLDs & Medicines’ Supply

Products Categories

If you have any question, please feel free to email us. We will touch with you as soon as possible.

RLDs & Medicines’ Supply

Tafinlar

Product name(English)	Dabrafenib mesylate Capsules
Brand Name	Tafinlar
MA Holder	Novartis Europharm Limited(Ireland)
Marketed Country	China
Strenght & package	50mg *120Capsules/bottle/pack

Send Inquiry

Product Details

Product name(English)	Dabrafenib mesylate Capsules
Brand Name	Tafinlar
MA Holder	Novartis Europharm Limited(Ireland)
Marketed Country	China
Strenght & package	50mg *120Capsules/bottle/pack
Manufacturer	Siegfried Barbera, S.L.; Novartis Pharmaceutical Manufacturing LLC(Spain；Slovenia)
Target Client	Supply for Wholesalers, Pharmacies,Private & Government Hospitals,Clinics,Agencies, and B2B

TOSUN PHARM was established in 1999. In China, As a company with more than 20 years of industry experience in China, TOSUN has established long-term and profound cooperative relationships with high-quality suppliers in 20 countries around the world, including the US,UK,EU,Australia,China,Japan,Singapore,HK etc. It has provided procurement services for more than 4,000 reference listed drugs(RLD/Comparator drugs) for more than 2,000 pharmaceutical companies in China and the world. We have accumulated rich purchasing experience and professional team.

At the same time, we also undertake the export of Chinese reference listed drugs(RLD/RS/comparator drug), clinical trial drugs and medicine such as Drugs In-shortage,Unlicensed Drugs,Branded Medicines and Generic Drugs to all over the world.

Supply for Wholesalers, Pharmacies, Private & Government Hospitals, Clinics,Agencies,and B2B. We source & supply commercially licensed medicines from manufacturers,agencies of manufacturer,wholesalers etc.

We have a robust supplier network around the world,which enables us to offer a diverse range of products to meet the needs of our customers. Our team is dedicated to ensuring timely delivery and providing exceptional customer service.